[EN] ACTIVATORS OF HEME REGULATED INHIBITOR KINASE (HRI)<br/>[FR] ACTIVATEURS DE LA KINASE INHIBITRICE RÉGULÉE PAR L'HÈME (HRI)
申请人:BRIGHAM & WOMENS HOSPITAL INC
公开号:WO2021072028A1
公开(公告)日:2021-04-15
The present application provides compounds that modulate the activity of one or more eIF2α kinases. Pharmaceutical compositions and methods of treating diseases related to one or more eIF2α kinases are also provided.
本申请提供了调节一个或多个eIF2α激酶活性的化合物。还提供了与一个或多个eIF2α激酶相关的疾病的药物组合物和治疗方法。